A Clinical Study of 12 Cases of Sarcoma of the Uterus.
- Author:
Il Soo PARK
;
Hyun Jung LEE
- Publication Type:Original Article
- Keywords:
Uterine sarcoma
- MeSH:
Animals;
Chemotherapy, Adjuvant;
Connective Tissue;
Female;
Fertility;
Follow-Up Studies;
Gyeongsangbuk-do;
Gynecology;
Humans;
Hysterectomy;
Leiomyosarcoma;
Mice;
Myometrium;
Obstetrics;
Prognosis;
Sarcoma*;
Uterus*
- From:Korean Journal of Gynecologic Oncology and Colposcopy
2000;11(4):404-410
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: Sarcoma of uterus is originated from uterine muscles and/or connective tissues and rare and most lethal of all primary uterine tumors. The purpose of this study was to evaluate the clinical outcome of 12 patients diagnosed primary uterine sarcoma at the Department of Obstetrics and Gynecology in Kyungpook National University Hospital between 1984 and 1998 for 15 years. METHODS: After review of chart in twelve patients, data including clinical and histologic findings, treatment and outcome were analysed. RESULTS: The most common histologic finding was leiomyosarcoma(6cases, 50%) and the age of patients ranged 24 to 69 years and the average age was 43.25 years and two patients were nulliparous. The most common sign was abnormal uterine or vaginal bleeding(48%), and pelvic cavity or vaginal mass(16%), pelvic pain(16%), no symptom(16%), in order of frequency. The distribution by FIGO clinical stage was four cases(33%) for stage I, one case (8%) for stageII, one case(8%) for stage III, six cases (50%) for stage N. The nine cases received hysterectomy with or without BSO. Two cases received myomectomy to preserve fertility. The mean follow-up duration was 39.6 months. CONCLUSION: Uterine sarcoma is an uncommon and aggressive tumors with a poor prognosis. Leiomyosarcoma is the most frequent histologic type(50%). Stage I uterine sarcoma with or without adjuvant chemotherapy has better prognosis than other stages.
